Results 31 to 40 of about 1,467,260 (242)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib

open access: yesRMD Open, 2019
Objectives Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). We examined response to tofacitinib 5 or 10 mg two times a day in patients with seropositive vs seronegative RA.Methods Data were pooled from five Phase III ...
Peter Nash   +6 more
doaj   +1 more source

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS [PDF]

open access: yesBasrah Journal of Surgery, 2014
This study aimed to examine the value of anti peptidylarginine deiminase (anti-PADI-4) antibody and anti-cyclic citrullinated peptide (anti-CCP) antibody among Iraqi patients with RA and to determine whether the activity and severity in RA patients are ...
Hassan J Hasony   +1 more
doaj   +1 more source

Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

open access: yesReumatismo, 2011
Objective: To assess the role of anti-cyclic citrullinated peptide (CCP) antibody detection in synovial fluid (SF) of RA patients compared to OA patients.
G. Valesini   +4 more
doaj   +1 more source

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2007
Background Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been of diagnostic value in Northern European Caucasian patients with rheumatoid arthritis (RA).
Theodoridou Katerina   +4 more
doaj   +1 more source

7- DIAGNOSTIC VALUE OF ANTIBODIES TO CITRULLINE CONTAINING PEPTIDES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SOUTHERN IRAQ43 [PDF]

open access: yesBasrah Journal of Surgery, 2009
A serological study has been done in Al-Nassiriyha, southern Iraq, from December 2006 to August 2007 designed to determine the frequency of anti-cyclic citrullinated peptide antibody (anti-CCP) in a group of patients with rheumatoid arthritis for ...
THURAYA J MEZAL   +3 more
doaj   +1 more source

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis

open access: yesRevista Brasileira de Reumatologia
Objective: The aim of this study was to assess the relationship between the two types of posttranslational modifications of proteins in RA: glycosylation on the example of carbohydrate-deficient transferrin and citrullination by means of autoantibodies ...
Monika Gudowska   +6 more
doaj   +1 more source

CCP Supplementary Materials

open access: yes, 2019
<p>Supplementary Materials for the CCP paper</p ...
CCP
core   +1 more source

Correlation between ACPA levels and disease parameters in 32 anti-CCP-positive RA patients.

open access: yes, 2018
Correlation between ACPA levels and disease parameters in 32 anti-CCP-positive RA patients.
Allan Stensballe (293505)   +5 more
core   +1 more source

Clinical utility of the anti-CCP assay in patients with rheumatic diseases [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2003
To determine the frequency of antibodies to cyclic citrullinated peptides (CCP) in a group of patients with a diversity of rheumatic diseases.249 consecutive sera from an arthritis clinic sent for rheumatology testing were selected for testing with the anti-CCP2 assays and for the presence of rheumatoid factor (RF).
D M, Lee, P H, Schur
openaire   +2 more sources

Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods We reviewed the Retraction Watch database to identify retracted articles in rheumatology. We recorded the main study characteristics, authors’ countries, reasons for retraction, time from publication to retraction, and trends over time ...
Anna Maria Vettori, Michele Iudici
wiley   +1 more source

Home - About - Disclaimer - Privacy